Society of Urodynamics, Female Pelvic
Medicine & Urogenital Reconstruction
Find a Member
Conflict of Interest Policy
Travel & Transportation
Needs & Objectives
NAU iOS App
Care Pathways – OAB CCP
Billing and Coding
Lifetime Achievement Award
Distinguished Service Award
Continence Care Champion Award
Clinical Essay Award
Basic Science Essay Award
Basic Science Podium Award
Basic Science Poster Award
Resident Travel Awards
Neuromodulation Research Grant Winners
Chemodenervation Grant Winners
OAB Fecal Incontinence Grant Winners
OAB Urgency Urinary Incontinence Grant Winners
Fellowship Updates & Announcements
Visiting Professorship in Pennsylvania
Dr. Reynolds visits Penn State Milton S. Hershey Medical Center
read more »
Groups Reaffirm Position on Use of Vaginal Mesh for Surgical Treatment of Stress Urinary Incontinence
read more »
2017 SUFU Research Foundation Resident Preceptorship
read more »
Announcing the SUFU Visiting Professorship
This 1-day visiting professorship will be offered to interested training programs and will consist of a lecture series from a member of the SUFU Executive Committee encompassing all aspects of FPMRS, Urodynamics, and Neurourology.
read more »
Overactive Bladder Clinical (OAB) Care Pathway
SUFU is providing the Overactive Bladder Clinical Care Pathway for use by providers and patients.
Overactive Bladder CCP Provider Flowchart »
Overactive Bladder CCP Patient Roadmap »
Updates & Announcements
NAU Online Journal
Donate to the
SUFU Research Foundation
News & Announcements
Diokno-Lapides Essay Contest
Announcing the Diokno-Lapides Essay Contest is NOW OPEN to all physicians, PhD scientists, and MD and PhD trainees throughout the world! ...
SUNA Core Curriculum for Urologic Nursing
The first edition of the SUNA Core Curriculum for Urologic Nursing is now available. This comprehensive publication is an excellent resource for all urologic nurses....
ICS-SUFU Early Career promotion
ICS now offers a special reduced rate for SUFU early career professionals. For just £40 you can become an ICS early career professional member! ...
2017 Early-Career Investigators Workshop (ECIW) | Now Accepting Nominations
Nominations are now being accepted for the 2017 Early-Career Investigators Workshop! The deadline to submit nominations is Friday, March 31, 2017. ...
Neurourology and Urodynamics
Natural history of post‐void residual urine volume over 5 years in community‐dwelling older men: The Concord Health and Ageing in Men Project
Wednesday, September 20, 2017
Aims To describe the natural history of post‐void residual urine volume (PVR) in community‐dwelling older men. Methods The Concord Health and Ageing in Men Project involves a representative sample of community‐dwelling men aged 70 and older in a defined geographic area of Sydney, Australia. PVR were measured at baseline and 2‐year and 5‐year follow‐up. The measurements were considered valid when the voided volumes were 150 mL and over. Three‐hundred twenty‐nine men without conditions that are likely to alter PVR (neurological disorders, prostate cancer, and a history of urological treatment) were included in the analyses. Results Baseline PVR were 0‐49 mL in 183 men, 50‐99 mL in 59 men, 100‐199 mL in 72 men, 200‐399 mL in 11 men, and 400 mL and over in 4 men. Thirteen out of 314 (4%) men with a baseline PVR of 0‐199 mL and 2 out of 11 (18%) men with a baseline PVR of 200‐399 mL had surgery for benign prostate enlargement (BPE) or indwelling catheterization over 5 years compared to three out of four men (75%) with a PVR of 400 mL and over. In all 101 men with a baseline PVR of less than 400 mL who did not receive urological treatment during follow‐up and had valid PVR data for both 2‐year and 5‐year follow‐up, PVR did not exceed 400 mL at either follow‐up time point. Conclusion Conservative management may be appropriate for most older men with incidentally found elevated PVR of up to 400 mL.
Reliability of urinary cytology and cystoscopy for the screening and diagnosis of bladder cancer in patients with neurogenic bladder: A systematic review
Tuesday, September 19, 2017
Aims To assess the reliability of urinary cytology and cystoscopy to screen and diagnose bladder cancer in patients with NB. Patients and Methods A systematic literature search of the Medline and Embase databases was performed in April 2017. Data extraction was performed by two independent reviewers. A narrative synthesis was made. Results Out of 220 records assessed, 15 were included in this systematic review. All studies were prospective or retrospective series with no control group. Cystoscopy allowed the detection of asymptomatic bladder cancer in 0‐10 patients, with a screening sensitivity (available in only one study) of 0%, a screening specificity ranging from 65% to 90%, and a yield in detecting asymptomatic bladder cancer of 0% in all series where it could be calculated. Urinary cytology allowed the detection of bladder cancer in asymptomatic patients in 0‐12 patients, with a screening sensitivity of 71%, a screening specificity ranging from 92% to 97% and a yield ranging from 0% to 1.25%. Sensitivity of cystoscopy for diagnosis of bladder cancer ranged from 27% to 81% and specificity was 54% in the only study where it could be calculated. Sensitivity of urinary cytology for diagnosis of bladder cancer was 0‐72% and specificity was 100%. Conclusion There is currently insufficient data to support formal recommendations of using both tools in the screening of bladder cancer in patients with neurogenic bladder. Urinary cytology outperformed cystoscopy for screening and might be the best tool currently available.
Find a Urologist